{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T03:34:11Z","timestamp":1769398451128,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2928,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1038\/sj.ki.5002550","type":"journal-article","created":{"date-parts":[[2007,9,19]],"date-time":"2007-09-19T14:46:46Z","timestamp":1190213206000},"page":"1358-1366","source":"Crossref","is-referenced-by-count":55,"title":["VEGF receptor inhibition slows the progression of polycystic kidney disease"],"prefix":"10.1016","volume":"72","author":[{"given":"Y.","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Faubel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.W.","family":"Schrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.L.","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5002550_bb0010","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.2479987","article-title":"Vascular permeability factor, an endothelial cell mitogen related to PDGF","volume":"246","author":"Keck","year":"1989","journal-title":"Science"},{"key":"10.1038\/sj.ki.5002550_bb0015","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen","volume":"246","author":"Leung","year":"1989","journal-title":"Science"},{"key":"10.1038\/sj.ki.5002550_bb0020","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/0006-291X(89)92729-0","article-title":"Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family","volume":"165","author":"Tischer","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/sj.ki.5002550_bb0025","doi-asserted-by":"crossref","first-page":"F905","DOI":"10.1152\/ajprenal.2000.278.6.F905","article-title":"Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells","volume":"278","author":"Kanellis","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/sj.ki.5002550_bb0030","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1128\/MCB.25.17.7441-7448.2005","article-title":"Vascular endothelial growth factor induces branching morphogenesis\/tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion","volume":"25","author":"Karihaloo","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1038\/sj.ki.5002550_bb0035","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jnci\/87.7.506","article-title":"Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma","volume":"87","author":"Boocock","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/sj.ki.5002550_bb0040","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0022-5347(05)67414-9","article-title":"Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues","volume":"164","author":"Hahn","year":"2000","journal-title":"J Urol"},{"issue":"Suppl 2","key":"10.1038\/sj.ki.5002550_bb0045","first-page":"100","article-title":"Expression of vascular endothelial growth factor (VEGF) and its receptor FLK-1 in non-small cell lung cancer (NSCLC)\u2014a preliminary report","volume":"39","author":"Dziadziuszko","year":"2001","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1038\/sj.ki.5002550_bb0050","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3748\/wjg.v7.i4.500","article-title":"Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma","volume":"7","author":"Liu","year":"2001","journal-title":"World J Gastroemterol"},{"key":"10.1038\/sj.ki.5002550_bb0055","first-page":"1255","article-title":"Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas","volume":"143","author":"Brown","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.ki.5002550_bb0060","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1006\/bbrc.1993.1106","article-title":"Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors","volume":"190","author":"Gitay-Goren","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/sj.ki.5002550_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ki.1994.253","article-title":"Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease","volume":"46","author":"Schafer","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002550_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMra022161","article-title":"Polycystic kidney disease","volume":"350","author":"Wilson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5002550_bb0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ki.1991.80","article-title":"C-myc as an inducer of polycystic kidney disease in transgenic mice","volume":"39","author":"Trudel","year":"1991","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002550_bb0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 3","key":"10.1038\/sj.ki.5002550_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000088479","article-title":"VEGF as a therapeutic target in cancer","volume":"69","author":"Ferrara","year":"2005","journal-title":"Oncology"},{"key":"10.1038\/sj.ki.5002550_bb0090","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/nar\/27.13.2569","article-title":"Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA","volume":"27","author":"Parry","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/sj.ki.5002550_bb0095","first-page":"2094","article-title":"Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors","volume":"6","author":"Pavco","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1038\/sj.ki.5002550_bb0100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/oli.1.1999.9.271","article-title":"Pharmacokinetics of an antiangiogenic ribozyme (ANGIOZYME) in the mouse","volume":"9","author":"Sandberg","year":"1999","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"10.1038\/sj.ki.5002550_bb0105","first-page":"1051","article-title":"Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys","volume":"142","author":"Schaffner","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.ki.5002550_bb0110","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1172\/JCI117858","article-title":"Increased gene expression for VEGF and the VEGF receptors KDR\/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide","volume":"95","author":"Tuder","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5002550_bb0115","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1038\/sj.ki.5002550_bb0120","doi-asserted-by":"crossref","first-page":"23659","DOI":"10.1074\/jbc.272.38.23659","article-title":"Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1\/KDR, is up-regulated by hypoxia","volume":"272","author":"Gerber","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5002550_bb0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/blood.V95.1.189","article-title":"Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide","volume":"95","author":"Kimura","year":"2000","journal-title":"Blood"},{"key":"10.1038\/sj.ki.5002550_bb0130","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2005-12-007484","article-title":"VEGF regulates the mobilisation of VEGFR-2\/KDR from an intracellular endothelial storage compartment","volume":"108","author":"Gampel","year":"2006","journal-title":"Blood"},{"key":"10.1038\/sj.ki.5002550_bb0135","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1042\/CS20040370","article-title":"The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions","volume":"109","author":"Takahashi","year":"2005","journal-title":"Clin Sci (Lond)"},{"key":"10.1038\/sj.ki.5002550_bb0140","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0959-8049(00)00003-4","article-title":"Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients","volume":"36","author":"Lee","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1038\/sj.ki.5002550_bb0145","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.21865","article-title":"The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma","volume":"119","author":"Wu","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1038\/sj.ki.5002550_bb0150","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/bjc.1998.164","article-title":"Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer","volume":"77","author":"Tokunaga","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1038\/sj.ki.5002550_bb0155","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2337\/diabetes.48.11.2229","article-title":"Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes","volume":"48","author":"Cooper","year":"1999","journal-title":"Diabetes"},{"key":"10.1038\/sj.ki.5002550_bb0160","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/bbrc.1996.1355","article-title":"Identification of a natural soluble form of the vascular endothelial growth factor receptor FLT-1, and its heterodimerization with KDR","volume":"226","author":"Kendall","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/sj.ki.5002550_bb0165","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.ajog.2006.03.065","article-title":"Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction","volume":"195","author":"Savvidou","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1038\/sj.ki.5002550_bb0170","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/1535-7163.MCT-04-0210","article-title":"A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors","volume":"4","author":"Weng","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/sj.ki.5002550_bb0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/380435a0","article-title":"Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele","volume":"380","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"key":"10.1038\/sj.ki.5002550_bb0180","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/sj.ki.5000314","article-title":"VEGF receptor 2 blockade leads to renal cyst formation in mice","volume":"69","author":"McGrath-Morrow","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002550_bb0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1523-1755.2001.00768.x","article-title":"Angiogenesis in autosomal-dominant polycystic kidney disease","volume":"60","author":"Bello-Reuss","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002550_bb0190","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.ki.5001725","article-title":"Evidence of angiogenesis and microvascular regression in autosomal-dominant polycystic kidney disease kidneys: a corrosion cast study","volume":"70","author":"Wei","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002550_bb0195","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-5347(17)73123-0","article-title":"The arterial supply of the congenital polycystic kidney and its relation to the clinical picture","volume":"21","author":"Ritter","year":"1929","journal-title":"J Urol"},{"key":"10.1038\/sj.ki.5002550_bb0200","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archinte.1931.00140210163013","article-title":"Hypertension in cases of congenital polycystic kidney","volume":"47","author":"Schacht","year":"1931","journal-title":"Arch Intern Med"},{"key":"10.1038\/sj.ki.5002550_bb0205","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/ki.1992.413","article-title":"Renal histology in polycystic kidney disease with incipient and advanced renal failure","volume":"42","author":"Zeier","year":"1992","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002550_bb0210","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ki.1994.374","article-title":"Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members","volume":"46","author":"Barrett","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002550_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/08977199509003209","article-title":"Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues","volume":"12","author":"Bacic","year":"1995","journal-title":"Growth Factors"},{"key":"10.1038\/sj.ki.5002550_bb0220","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1242\/dev.114.2.521","article-title":"Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation","volume":"114","author":"Breier","year":"1992","journal-title":"Development"},{"key":"10.1038\/sj.ki.5002550_bb0225","doi-asserted-by":"crossref","first-page":"8915","DOI":"10.1073\/pnas.90.19.8915","article-title":"Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth","volume":"90","author":"Peters","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.ki.5002550_bb0230","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1681\/ASN.V10102125","article-title":"Vascular endothelial growth factor induces nephrogenesis and vasculogenesis","volume":"10","author":"Tufro","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002550_bb0235","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5002550_bb0240","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5002550_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2710.2007.00800.x","article-title":"Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer","volume":"32","author":"Kr\u00e4mer","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.1038\/sj.ki.5002550_bb0250","doi-asserted-by":"crossref","first-page":"12605","DOI":"10.1074\/jbc.C300012200","article-title":"Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria","volume":"278","author":"Sugimoto","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5002550_bb0255","first-page":"295","article-title":"Autosomal dominant polycystic kidney disease: clinical and genetic aspects","volume":"10","author":"Sessa","year":"1997","journal-title":"J Nephrol"},{"key":"10.1038\/sj.ki.5002550_bb0260","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/CS20040370","article-title":"The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions","volume":"109","author":"Takahashi","year":"2005","journal-title":"Clin Sci (Lond)"},{"key":"10.1038\/sj.ki.5002550_bb0265","doi-asserted-by":"crossref","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","article-title":"Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor","volume":"269","author":"Waltenberger","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5002550_bb0270","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1182\/blood-2006-04-016030","article-title":"Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocyte\/macrophages","volume":"108","author":"Murakami","year":"2006","journal-title":"Blood"},{"key":"10.1038\/sj.ki.5002550_bb0275","doi-asserted-by":"crossref","first-page":"14016","DOI":"10.1073\/pnas.0503544102","article-title":"VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice","volume":"102","author":"Niida","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.ki.5002550_bb0280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0272-6386(97)90039-1","article-title":"Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats","volume":"29","author":"Cowley","year":"1997","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815525805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815525805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T23:40:44Z","timestamp":1629762044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815525805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0085253815525805"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5002550","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}